RecruitingNot ApplicableNCT07821515

Does Paracetamol Influence the Release of Gut Hormones, Glucose Absorption and Glycemia?


Sponsor

University of Copenhagen

Enrollment

12 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study aim is to determine whether acute inhibition of endogenous prostaglandin synthesis by paracetamol affects the release of gut hormones, glucose absorption and glycemia in healthy young individuals


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Paracetamol and Placebo for people with healthy young adults and physiology. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERParacetamol

Paracetamol is used as a tool to block prostaglandin synthesis

OTHERPlacebo

A placebo will be administered to be able to determine the effect of paracetamol on prostaglandin synthesis


Locations(2)

Department of Biomedical Sciences, The Panum Institute, University of Copenhagen,

Copenhagen, Capital, Denmark

Hvidovre Hospital, Copenhagen University Hospital

Hvidovre, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07821515


Related Trials